Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,68 USD | -.--% | -4,55% | -44,19% |
Omzet 2024 * | 7,98 mln. 7,36 mln. | Omzet 2025 * | 64,05 mln. 59,06 mln. | Marktkapitalisatie | 43,55 mln. 40,16 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -7 mln. -6,45 mln. | Nettowinst (verlies) 2025 * | 44 mln. 40,57 mln. | EV/omzet 2024 * | 5,46 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,68 x |
K/w-verhouding 2024 * |
-5,89
x | K/w-verhouding 2025 * |
0,94
x | Werknemers | 14 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 93,54% |
Recentste transcriptie over Ocuphire Pharma, Inc.
1 week | -4,55% | ||
1 maand | +5,99% | ||
3 maanden | -33,73% | ||
6 maanden | -44,92% | ||
Lopend jaar | -44,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Magrath
CEO | Chief Executive Officer | 40 | 01/11 |
Nirav Jhaveri
DFI | Director of Finance/CFO | 46 | 14/02 |
Barbara Withers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 01-11-20 |
James Manuso
BRD | Director/Board Member | 75 | 01-01-19 |
Susan Benton
BRD | Director/Board Member | 59 | 01-11-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 1,68 | -.--% | 51 597 |
30-05-24 | 1,68 | -1,47% | 67 790 |
29-05-24 | 1,705 | +2,10% | 93 158 |
28-05-24 | 1,67 | -5,11% | 321 880 |
24-05-24 | 1,76 | +2,92% | 70 679 |
uitgestelde koers Nasdaq, 31 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-44,19% | 43,55 mln. | |
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. |